For retail sale medicaments with other antibiotics market in Poland

Earlier Report Observations

The market volume for retail sale medicaments containing other antibiotics in Poland declined from 186.1 million USD in 2018 to 123.9 million USD in 2022. A key driver was the reduction in the number of pharmacies, which limited availability and distribution. This was compounded by a growing consumer shift toward self-medication, reducing demand for prescription antibiotics as patients opted for over-the-counter alternatives.

Domestic production fell from 53.4 million USD in 2018 to 46.9 million USD in 2020 before recovering slightly to 49.8 million USD in 2022. Import values also dropped from 212.8 million USD to 171.3 million USD over the same period, influenced by weaker economic conditions that constrained household healthcare spending. The broader pharmaceutical market in Poland showed growth in subsequent years, expanding by 9.5% in 2023, though this segment remained under pressure.

Global antibiotic shortages and rising resistance concerns emerged as potential influences on the market, reflecting wider industry challenges. However, the direct impact on the volume of retail sale medicaments with other antibiotics was not yet fully evident in the available data up to 2024.

Production for retail sale medicaments with other antibiotics in Poland

In value, 2017-2020, K $ US

Poland's production volume of retail sale medicaments containing other antibiotics declined for the third consecutive year. In 2020, output was valued at 46 891 thousand US dollars, representing an 8.3% decrease compared to 2019. Over the period from 2017 to 2020, production fell by 16.8%, with a compound annual growth rate of -6.0%.

Annual dynamics of production in Poland in value, 2017-2020, K $ US

Exports for retail sale medicaments with other antibiotics from Poland

Exports in kind, t

In 2020, deliveries of retail sale medicaments with other antibiotics from Poland amounted to 3 206 tonnes, marking a 4.3% decline from 2019. The highest volume was recorded in 2019 at 3 349 tonnes. The largest increase occurred in 2018, with a growth of 4.9%.

Annual dynamics of product's exports from Poland in kind, 2017-2020, t

The export market for these medicaments in kind from 2017 to 2020 was diverse. Germany accounted for 23.9% of exports in kind, Russia for 12.0%, and Italy for 11.5%, together making up 47.5% of total flows. The remaining 52.5% was distributed among numerous other countries.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Poland in kind, 2017-2020

Exports in value, M $ US

After two years of growth, Poland's exports of retail sale medicaments with other antibiotics declined. In 2020, exports totaled 89.0 million US dollars, reflecting a modest decrease of 5.2% from the previous year. Over the 2017-2020 period, exports increased by 30.1%, with a compound annual growth rate of 9.2%. The peak value was recorded in 2019 at 93.9 million US dollars, which also saw the largest increase of 17.4%.

Annual dynamics of product's exports from Poland in value, 2017-2020, M $ US

From 2017 to 2020, Germany, Russia, and Vietnam were the largest buyers of these medicaments from Poland in value terms, but none dominated the market. Germany accounted for 15.4% of exports in value, Russia for 14.3%, and Vietnam for 9.8%, together representing 39.5% of total exports. The rest was spread across a broad range of smaller partners.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Poland in value, 2017-2020

Imports for retail sale medicaments with other antibiotics to Poland

Imports in kind, t

Poland's imports of retail sale medicaments with other antibiotics increased for the third consecutive year. In 2020, imports reached 2 582 tonnes, showing a limited advance of 3.1% compared to 2019. Between 2017 and 2020, imports grew by 14.3%, equating to an annualized rate of 4.5%.

Annual dynamics of product's imports to Poland in kind, 2017-2020, t

From 2017 to 2020, imports in kind were sourced from a wide set of partner countries. Spain accounted for 20.4% of imports in kind, the Netherlands for 15.7%, and Italy for 13.2%, together making up 49.3% of total flows.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Poland in kind, 2017-2020

Imports in value, M $ US

Poland's imports of retail sale medicaments with other antibiotics declined for the second consecutive year. In 2020, imports stood at 171.3 million US dollars, representing a modest decrease of 6.4% from the previous year. The highest value was recorded in 2018 at 212.8 million US dollars. The largest decline occurred in 2019, with a drop of 14.0%, while the largest increase was in 2018, with a rise of 25.5%.

Annual dynamics of product's imports to Poland in value, 2017-2020, M $ US

Over the 2017-2020 period, the country breakdown of imports in value terms was scattered. Italy accounted for 18.6% of imports in value, the United Kingdom for 12.0%, and Ireland for 8.5%, together representing 39.1% of total flows, with no single partner emerging as clearly dominant.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Poland in value, 2017-2020